Key facts
- Notable investors include Investissement Quebec, Glen Ventures, Longevity Venture Partners.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Sensifai Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Sensifai Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Sensifai Health
Developer of an AI-powered health monitoring platform designed to detect early signs of systemic inflammation before symptoms appear. The company offers continuous analysis of data from wearable biometric sensors, enabling individuals at risk of immune-related conditions to receive early intervention and improved long-term health outcomes.
- Sector
- Information Technology
- HQ
- Montreal, Canada
- Founded
- 2023
- Employees
- 9
- Website
- sensifai.health/
- Ownership
- Privately Held (backing)
Sensifai Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Sensifai Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Sensifai Health in its N-PORT filings yet. We sweep new filings monthly.